Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients-Reference-Cited by-同舟云学术

Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients

Published:2013-06 Issue:3 Volume:61 Page:88-92
ISSN:0369-8114
Container-title:Pathologie Biologie
language:en
Short-container-title:Pathologie Biologie

Author:

Smires F.Z.,Habbal R.,Moreau C.,Assaidi A.,Loriot M.A.,Nadifi S.

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Factors affecting the maintenance dose of warfarin;James;J Clin Pathol,1992

2. Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients;Leung;Blood,2001

3. Interindividual variability in sensitivity to warfarin-nature or nurture?;Loebstein;Clin Pharmacol Ther,2001

4. Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose;Zhao;Clin Pharmacol Ther,2004

5. Antithrombotic therapy in deep vein thrombosis and pulmonary embolism;Hirsh;Am Heart J,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of clinical pharmacogenetics Studies in African populations;Personalized Medicine;2020-03

2. Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients;Drug Discoveries & Therapeutics;2018-04-30

3. Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population;European Journal of Clinical Pharmacology;2018-02-26

4. Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region;Drugs in R&D;2017-07-26

5. Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis;Medicine;2017-03